p38 MAP kinase inhibitors as potential therapeutic drugs for neural diseases

S Yasuda, H Sugiura, H Tanaka… - … System Agents in …, 2011 - ingentaconnect.com
Mammalian p38 mitogen-activated protein kinases (MAPKs) are activated by various cellular
stresses, as well as in response to inflammatory cytokines. In the central nervous systems …

[HTML][HTML] The p38α mitogen-activated protein kinase as a central nervous system drug discovery target

AS Borders, L De Almeida, LJ Van Eldik… - BMC neuroscience, 2008 - Springer
Protein kinases are critical modulators of a variety of cellular signal transduction pathways,
and abnormal phosphorylation events can be a cause or contributor to disease progression …

Clinical candidates of small molecule p38 MAPK inhibitors for inflammatory diseases

L Xing - Map Kinase, 2015 - pagepressjournals.org
The trigger and etiology of chronic inflammatory diseases are not well understood, hindering
the development of efficient therapeutic approaches. The observation that abnormal activity …

CNS-Active p38α MAPK Inhibitors for the Management of Neuroinflammatory Diseases: Medicinal Chemical Properties and Therapeutic Capabilities

M Valipour, M Mohammadi, H Valipour - Molecular Neurobiology, 2023 - Springer
During the last two decades, many p38α mitogen-activated protein kinase (p38α MAPK)
inhibitors have been developed and tested in preclinical/clinical studies for the treatment of …

Targeting p38 MAPK pathway for the treatment of Alzheimer's disease

L Munoz, AJ Ammit - Neuropharmacology, 2010 - Elsevier
Accumulating evidence indicates that p38 mitogen-activated protein kinase (MAPK) could
play more than one role in Alzheimer's disease (AD) pathophysiology and that patients …

[HTML][HTML] Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer's disease

JK Lee, NJ Kim - Molecules, 2017 - mdpi.com
P38 mitogen-activated protein kinase (MAPK) is a crucial target for chronic inflammatory
diseases. Alzheimer's disease (AD) is characterized by the presence of amyloid plaques …

p38 MAPK: a potential target of chronic pain

X Lin, M Wang, J Zhang, R Xu - Current medicinal chemistry, 2014 - ingentaconnect.com
p38 mitogen-activated protein kinases (p38 MAPK, p38) consist of 4 subunits: p38α, p38β,
p38γ and p38δ. They play a well-recognized role in regulating intracellular signaling …

[HTML][HTML] Involvement of p38 MAPK in synaptic function and dysfunction

C Falcicchia, F Tozzi, O Arancio, DM Watterson… - International journal of …, 2020 - mdpi.com
Many studies have revealed a central role of p38 MAPK in neuronal plasticity and the
regulation of long-term changes in synaptic efficacy, such as long-term potentiation (LTP) …

The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer

HY Yong, MS Koh, A Moon - Expert opinion on investigational …, 2009 - Taylor & Francis
Background: The p38 mitogen-activated protein kinase (MAPK) is activated by various pro-
inflammatory and stressful stimuli. Mounting evidence suggests that the p38 MAPK signaling …

[HTML][HTML] The p38 MAP kinase family as regulators of proinflammatory cytokine production in degenerative diseases of the CNS

AD Bachstetter, LJ Van Eldik - Aging and disease, 2010 - ncbi.nlm.nih.gov
Inflammation in the central nervous system (CNS) is a common feature of age-related
neurodegenerative diseases. Proinflammatory cytokines, such as IL-1β and TNFα, are …